Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome
Authors:
- 2 June 2005
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 24 (6) , 377-383
Abstract
Community-acquired pneumonia (CAP) of mixed etiology has increasingly been appreciated in the literature, but its clinical significance remains unknown. The aim of this analysis was to describe the prevalence, clinical characteristics, and outcome of CAP of mixed etiology. Data were obtained from a 2-year prospective study of consecutive patients with CAP in whom an extensive microbiological workup was performed. Predefined strict criteria were used to establish the etiology. A total of 493 patients were included. A single pathogen was detected in 222 (45%) cases and two or more pathogens in 28 (5.7%) cases. Mixed infections were seen across all age groups and in patients treated both in hospital and as outpatients. The most frequent combinations of pathogens were those of a bacterium plus an “atypical” organism (28.6%) and of two bacterial organisms (28.6%). Compared with patients with monomicrobial pneumonia, patients with mixed pneumonia were more likely to have underlying conditions (64% vs. 45%, p=0.04) and dementia (25% vs. 10%, p=0.02). The incidence of a defined series of complications was higher in patients with mixed pneumonia (39.3% vs. 18.6%; OR=2.84; p=0.02). Community-acquired pneumonia of mixed etiology is uncommon. Patients with mixed pneumonia are more likely to have underlying medical conditions, and they may have a more severe course of disease.Keywords
This publication has 42 references indexed in Scilit:
- Contribution of a Urinary Antigen Assay (Binax NOW) to the Early Diagnosis of Pneumococcal PneumoniaClinical Infectious Diseases, 2004
- Chlamydiaspecies as a cause of community-acquired pneumonia in CanadaEuropean Respiratory Journal, 2003
- Editorial Commentary: What is Optimal Antimicrobial Therapy for Bacteremic Pneumococcal Pneumonia?Clinical Infectious Diseases, 2003
- Community-Acquired PneumoniaMedicine, 2001
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- The Etiology of Community-Acquired Pneumonia among Hospitalized Patients during a Chlamydia pneumoniae Epidemic in FinlandThe Journal of Infectious Diseases, 1995
- Viral potentiation of bacterial superinfection of the respiratory tractTrends in Microbiology, 1995
- Diagnosis of Pneumonia by Cultures, Bacterial and Viral Antigen Detection Tests, and Serology with Special Reference to Antibodies against Pneumococcal AntigensThe Journal of Infectious Diseases, 1991
- Etiology of community-acquired pneumonia in out-patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Etiology of community-acquired pneumonia in patients requiring hospitalizationEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985